The data presented here indicate that the expression of p21 is in fact downregulated in fulvestrant-resistant 182R-6 breast cancer cells (supplementary Fig. S2), in agreement with a previous report47, and this downregulation may contribute to the lack of sensitivity of these breast cancer cells to fulvestrant. Here, CDKN1A is linked to breast carcinoma.